↓ Skip to main content

Dove Medical Press

Article Metrics

Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
3 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
24 Mendeley
Title
Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
Published in
Neuropsychiatric Disease and Treatment, July 2021
DOI 10.2147/ndt.s312966
Pubmed ID
Authors

Shimaa Aboelbaha, Monica Zolezzi, Hazem Elewa

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 21%
Lecturer 4 17%
Student > Ph. D. Student 3 13%
Student > Bachelor 2 8%
Student > Master 2 8%
Other 3 13%
Unknown 5 21%
Readers by discipline Count As %
Medicine and Dentistry 5 21%
Nursing and Health Professions 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Computer Science 1 4%
Other 3 13%
Unknown 9 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2022.
All research outputs
#6,320,615
of 22,925,760 outputs
Outputs from Neuropsychiatric Disease and Treatment
#817
of 2,991 outputs
Outputs of similar age
#133,829
of 440,104 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#13
of 48 outputs
Altmetric has tracked 22,925,760 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,104 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.